The US recombinant therapeutic protein market is expanding due to the increasing adoption of advanced biologic therapies and growing demand for targeted treatment solutions. Strong biotechnology research capabilities, rising investments in drug development, and the presence of major pharmaceutical companies are supporting market growth. The increasing focus on personalized medicine and...